Results 241 to 250 of about 58,392 (301)

Theranostics, Gallium‑68, and Other Radionuclides: A Pathway to Personalized Diagnosis and Treatment: Proceedings of the 1st World Congress on Gallium-68 and Peptide Receptor Targeted Radiation Therapy, Bad Berka, Germany, June 2010

, 2013
Michael K. Schultz
openalex   +1 more source

PReCedeNT trial: Phase III randomized-controlled trial of Lutetium - 177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) plus Chemotherapy versus PRRT alone in FDG-avid, Well-differentiated Gastroenteropancreatic neuroendocrine tumors (GEP-NETs). [PDF]

BMC Cancer
Puranik AD, Dev ID, Yadav S, Rangarajan V, Agrawal A, Basu S, Chaudhari VA, Ramaswamy A, Ostwal V, Bhandare MS, Shrikhande SV, Parghane RV, Bhargava P, Bal MM, Yadav S, Patkar S, Goel M, Purandare NC, Shah S, Choudhury S, Ghosh S, Venkatachalam M.   +21 more
europepmc   +1 more source

Can Radionuclide Therapy be the Solution for Hepatitis B Virus Infection? [PDF]

Nucl Med Mol Imaging
Sung PS, Yoo IR.
europepmc   +1 more source

Peptide receptor radionuclide therapy with radiolabelled somatostatin analogues

, 2009
Lisa Bodei
openalex   +1 more source

An ACTH-Producing Neuroendocrine Tumor: Clinical Course of Multidisciplinary Therapy Including Peptide Receptor Radionuclide Therapy - A Case Report. [PDF]

Case Rep Oncol
Koizumi T, Sato A, Kitajima K, Yamazaki M, Kanazawa S, Notake T, Sato Y, Kobayashi S, Iwaya M, Umeda T, Komatsu M.   +10 more
europepmc   +1 more source

Efficacy of combined targeted radionuclide therapy and immune checkpoint Inhibition in animal tumour models: a systematic review and meta-analysis of the literature. [PDF]

Eur J Nucl Med Mol Imaging
Kleinendorst SC, Hooijmans CR, Muselaers S, Oosterwijk E, Konijnenberg M, Heskamp S, van Lith SAM.   +6 more
europepmc   +1 more source

Safety, dosimetry, and efficacy of an optimized long-acting somatostatin analog for peptide receptor radionuclide therapy in metastatic neuroendocrine tumors: From preclinical testing to first-in-human study

Wei Guo, Xuejun Wen, Yuhang Chen, Tianzhi Zhao, Jia Liu, Yucen Tao, Hao Fu, Hongjian Wang, Weizhi Xu, Yizhen Pang, Liang Zhao, Jinxiong Huang, Peng‐Fei Xu, Zhide Guo, Weibing Miao, Jingjing Zhang, Xiaoyuan Chen, Haojun Chen   +17 more
openalex   +1 more source

Targeted radionuclide therapy for patients with neuroendocrine tumours with focus on normal tissue response in 177-Lu-DOTATATE treatment

, 2016
Johanna Svensson
openalex   +1 more source

Efficacy and Safety of Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis of Comparative Studies.

Cureus
Zhao J, Pei X, Li Y.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Radionuclide Therapy

2022
The main purpose of this book is to create a reference for the indications, contraindications, patient selection, treatment practice, treatment side effect management, and follow-up of radionuclide treatments.Besides standard methods such as surgery, chemotherapy, radiotherapy, and hormone therapy, newly developed biological treatments, targeted ...
POLACK, BERNA, ACAR AKKAYA, EMİNE, BEKİŞ, RECEP   +2 more
  +13 more sources